These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34684404)

  • 1. Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus.
    Lim K; Kang M; Park J
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Kim Y; Chang Y; Kwon MJ; Hong YS; Kim MK; Sohn W; Cho YK; Shin H; Wild SH; Byrne CD; Ryu S
    Am J Gastroenterol; 2021 Nov; 116(11):2270-2278. PubMed ID: 34114568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of Cardiac Symptoms and Electrocardiographic Abnormalities for Advanced Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Kang MK; Kim MC
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837575
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
    Fujii H; Imajo K; Yoneda M; Nakahara T; Hyogo H; Takahashi H; Hara T; Tanaka S; Sumida Y; Eguchi Y; Chayama K; Nakajima A; Nishimoto N; Kawada N;
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1390-1395. PubMed ID: 30600551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
    Yilmaz Y; Senates E; Yesil A; Ergelen R; Colak Y
    J Diabetes Complications; 2014; 28(3):328-31. PubMed ID: 24602757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor.
    Aller R; Sigüenza R; Pina M; Laserna C; Antolín B; Burgueño B; Durà M; Izaola O; Primo D; de Luis DA
    Endocrine; 2020 Jun; 68(3):557-563. PubMed ID: 32239453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.
    Lee JI; Yu JH; Anh SG; Lee HW; Jeong J; Lee KS
    Oncologist; 2019 Aug; 24(8):e653-e661. PubMed ID: 30679317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
    Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
    JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
    Ortiz-Lopez C; Lomonaco R; Orsak B; Finch J; Chang Z; Kochunov VG; Hardies J; Cusi K
    Diabetes Care; 2012 Apr; 35(4):873-8. PubMed ID: 22374640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes.
    Li Y; Zhu S; Li B; Shao X; Liu X; Liu A; Wu B; Zhang Y; Wang H; Wang X; Deng K; Liu Q; Huang M; Liu H; Holthöfer H; Zou H
    Int Urol Nephrol; 2014 Sep; 46(9):1785-91. PubMed ID: 25099524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease.
    Hossain IA; Akter S; Bhuiyan FR; Shah MR; Rahman MK; Ali L
    BMC Res Notes; 2016 May; 9():266. PubMed ID: 27169860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.
    Dogan S; Celikbilek M; Yilmaz YK; Sarikaya S; Zararsiz G; Serin HI; Borekci E; Akyol L; Pirti I; Davarci SE
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):298-304. PubMed ID: 25629574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease.
    Chang X; Bian H; Xia M; Zhu X; Sun X; Yang X; Gao J; Lin H; Yan H; Gao X
    Diabetes Metab; 2022 Nov; 48(6):101377. PubMed ID: 35858659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease.
    Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
    Liver Int; 2019 Oct; 39(10):1884-1894. PubMed ID: 31226232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.
    Rotundo L; Persaud A; Feurdean M; Ahlawat S; Kim HS
    Clin Mol Hepatol; 2018 Dec; 24(4):392-401. PubMed ID: 30068065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study.
    Koo DJ; Lee MY; Jung I; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1016-1028. PubMed ID: 34674510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
    Koo DJ; Lee MY; Jung I; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
    PLoS One; 2021; 16(8):e0255535. PubMed ID: 34432804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.